The effects of contemporary treatment of DCIS on the risk of developing an ipsilateral invasive Breast cancer (iIBC) in the Dutch population.
Sena AlaeikhanehshirRenée S J M SchmitzAlexandra W van den Belt-DuseboutFrederieke H van DuijnhovenEllen VerschuurMaartje van SeijenMichael SchaapveldEsther H LipsJelle Wesselingnull nullPublished in: Breast cancer research and treatment (2023)
Although absolute risks of iIBC were low in patients treated for DCIS with either BCS or BCS + RT, risks remained higher in the BCS alone group compared to patients treated with BCS + RT for at least 10 years after DCIS diagnosis.